Is everyday skin fungus playing a bigger role in eczema than we ever realized? What if the culprit behind cradle cap, dupilumab facial redness and eczema flare-ups in puberty is hiding in plain sight, on the surface of our skin? Professor of Fungal Immunology from University of Zurich. Dr. Salome LeibundGut-Landmann, explains the secret world of skin fungi, how it affects eczema and a bold new project to convert fungi into skin helpers.

Literature Mentioned

Exeter secures £3.3 million grant to investigate treatment and prevention of eczema

A Case of Cutaneous Fungal Infection Following the Administration of Dupilumab

Retrospective Analysis of the Relationship Between Infantile Seborrheic Dermatitis and Atopic Dermatitis

Malassezia-associated skin diseases in the pediatric population

Dupilumab facial redness: Clinical characteristics and proposed treatment in a cohort

Advances on the role of mycobiome in atopic dermatitis

The devil is in the details, and in this episode of the Eczema Breakthroughs Podcast, we dive deep into smarter skin care for kids with eczema. Dr. Helen Brough (Director: Children’s Allergy Doctors, London), one of the leading experts in eczema treatment, shares step-by-step, evidence-based guidance on moisturizing, bathing, and proactive steroid use. Joining her is Dr. Amber Atwater (Clinical Associate Professor of Dermatology, George Washington University), who unpacks the tricky overlap between allergic contact dermatitis and atopic dermatitis, and why choosing low-allergen products is essential.

References

Emollients to Prevent Pediatric Eczema: A Randomized Clinical Trial

Eczema Care Online

Consumer Preferences, Product Characteristics, and Potentially Allergenic Ingredients in Best-selling Moisturizers

Emollients to Prevent Pediatric Eczema: A Randomized Clinical Trial

Skin Safe 100

Two new studies from the Society for Investigative Dermatology (SID) conference reveal how Staph bacteria use clever strategies to disarm the skin's barrier maintenance function and work with other bacteria to amplify inflammation. Join us for an interview with Dr. Nathan Archer and Dr. Laine Feller from John Hopkins School of Medicine who explain how Staph aureus bacteria uses its superantigen superpower to hinder lipid production ... and more new research from this year's SID meeting.